BioSpace News Archive

iCAD, Inc. (NASDAQ: ICAD), today announced it will host its 2nd annual virtual investor webinar, featuring leading clinical and administrative experts who will share unique perspectives on iCAD’s innovative cancer detection and treatment technologies, on Thursday, November 18, 2021, from 3:00 to 4:30 PM Eastern Time.

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has successfully completed its first research study evaluating MicroDose-MN™, a proprietary microneedle (“MN”) patch for the intradermal delivery of psychedelics, in delivering psilocybin.

Kazia Therapeutics Limited, an oncology-focused drug development company, is pleased to announce that PNOC022, a multi-drug phase II study in DIPG and diffuse midline gliomas, has been initiated at the University of California, San Francisco, with the first patient successfully enrolled to the study.

Scipher Medicine ® to Present at the Jeffries London Healthcare Conference

Establishment Labs Holdings Inc. today announced its participation in two upcoming investment conferences.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin, we or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today reported its financial results for the quarter ended September 30, 2021.

Transparency Market Research has published a new report titled, “Substance Abuse Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research has published a new report titled, ‘Interspinous Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global interspinous spacers market was valued at US$ 63.45 Mn in 2017 and is projected to expand at a high CAGR during the forecast period.

The global market for drug and gene delivery systems features a largely consolidated vendor landscape with only a handful companies accounting for a dominant share in the overall market, observes Transparency Market Research in a recent report.

The cluster headache market is estimated to experience significant growth opportunities in the upcoming years.